Who may omit locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a failure-pattern-based strategy in the immunotherapy era.
This retrospective real-world study analyzed 398 patients with de novo metastatic nasopharyngeal carcinoma treated with...